Literature DB >> 24676026

At-admission risk stratification for in-hospital life-threatening ventricular arrhythmias and death in non-ST elevation myocardial infarction patients.

Alessandro Zorzi1, Riccardo Turri1, Filippo Zilio1, Veronica Spadotto1, Anna Baritussio1, Francesco Peruzza1, Nicola Gasparetto1, Martina Perazzolo Marra1, Luisa Cacciavillani1, Armando Marzari1, Giuseppe Tarantini1, Sabino Iliceto1, Domenico Corrado2.   

Abstract

AIMS: Identification of patients with non-ST elevation acute myocardial infarction (NSTEMI) at higher risk of in-hospital life-threatening ventricular arrhythmias (LT-VA) and death is crucial for determining appropriate levels of care/monitoring during hospitalisation. We assessed predictors of in-hospital LT-VA and all-cause mortality in a consecutive series of NSTEMI patients. METHODS AND
RESULTS: We prospectively studied 1325 consecutive patients (69.7% males, median age 70 (61-79) years) presenting with NSTEMI and undergoing continuous electrocardiographic monitoring. The primary study end-point was the occurrence of spontaneous (unrelated to coronary interventions) in-hospital LT-VA, including sustained ventricular tachycardia and ventricular fibrillation; the secondary end-point was in-hospital mortality from all causes. Of 1325 patients, 21 (1.5%) experienced LT-VA and 62 (4.7%) died from either arrhythmias (n=1) or other causes (n=61). Seven of the 20 patients who survived LT-VA subsequently died of heart failure. Independent predictors of in-hospital LT-VA were the Global Registry of Acute Coronary Events (GRACE) score >140 (odds ratio (OR)=7.5; 95% confidence interval (CI) 1.7-33.3; p=0.008) and left ventricular ejection fraction (LV-EF)<35% (OR=4.1; 95% CI 1.7-10.3; p=0.002). GRACE score >140 (OR=14.6; 95% CI 3.4-62) and LV-EF <35% (OR=4.4; 95% CI 1.9-10) also predicted in-hospital all-cause death. The cumulative probability of in-hospital LT-VA and death was respectively 9.2% and 23% in the 98 (7.4%) patients with GRACE score >140 and LV-EF<35%, while it was respectively 0.2% and 0% among the 627 (47.3%) with GRACE score ≤140 and LV-EF ≥35%.
CONCLUSIONS: Simple risk stratification at admission based on GRACE score and echocardiographic LV-EF allows early identification of NSTEMI patients at higher risk of both in-hospital LT-VA and all-cause mortality. © The European Society of Cardiology 2014.

Entities:  

Keywords:  GRACE score; ST segment; ejection fraction; heart failure; myocardial infarction; risk stratification; ventricular arrhythmias

Mesh:

Year:  2014        PMID: 24676026     DOI: 10.1177/2048872614528796

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  4 in total

1.  Electrocardiographic measures of ventricular repolarization dispersion and arrhythmic outcomes among ST elevation myocardial infarction patients with pre-infarction angina undergoing primary percutaneous coronary intervention.

Authors:  Tarek A N Ahmed; Amr A Abdel-Nazeer; Ayman K M Hassan; Hosam Hasan-Ali; Amr A Youssef
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-09       Impact factor: 1.468

2.  Tp-e/QTc ratio, SYNTAX, and GRACE score in patients who underwent coronary angiography owing to acute coronary syndrome.

Authors:  Kadriye Gayretli Yayla; Çağrı Yayla; Mehmet Akif Erdöl; Mustafa Karanfil; Hamza Sunman; Faruk Aydın Yılmaz; Nail Burak Özbeyaz; Ayşe Nur Özkaya İbiş; Murat Tulmaç
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

3.  Risk of in-hospital life-threatening ventricular arrhythmia or death after ST-elevation myocardial infarction vs. the Takotsubo syndrome.

Authors:  Rickard Zeijlon; Jasmina Chamat; Israa Enabtawi; Sandeep Jha; Mohammed Munir Mohammed; Johan Wågerman; Vina Le; Aaron Shekka Espinosa; Erik Nyman; Elmir Omerovic; Björn Redfors
Journal:  ESC Heart Fail       Date:  2021-01-28

4.  Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention.

Authors:  Jaihoon Amon; Graham C Wong; Terry Lee; Joel Singer; John Cairns; Jay S Shavadia; Christopher Granger; Kenneth Gin; Tracy Y Wang; Sean van Diepen; Christopher B Fordyce
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.